Excited to share the great line-up for the #EMBO #TB meeting Kat Mayer-Barber, PhD Maziar Divangahi Stefan Oehlers @LuizCarvalhoLAB Olivier Neyrolles @ImmunologyKing Ramandeep Singh ....... Organized by A*STAR Infectious Diseases (ID) Labs ICGEB, New Delhi CSIR-CCMB meetings.embo.org/event/25-tuber…

After a gap of 4 years, the EMBO TB meeting returns, this time CCMB Hyderabad. Feb, 9-12, 2025 #Tuberculosis #heterogeneity #drugs #hostpathogeninteraction ICGEB, New Delhi Department of Biotechnology Amit Singhal Priscille Brodin meetings.embo.org/event/25-tuber…

Unofficial poster for the EMBO #TB meeting. Great line up - from East to West. Registration deadline is 20th Oct, We have started getting applications. @TB_NewsDaily CDC TB TB Alliance Gates Foundation Institut Pasteur, since 1887 EMBO Mol. Medicine ICGEB, New Delhi CCMB

Breaking News: Cabinet approves the BioE3 Policy! What's BioE3? 🧬 Biotechnology 💰 Economy 🌍 Environment 👥 Employment This policy aims to boost high-performance bio-manufacturing in India. Let's break it down for you! 🧵 #BioE3Policy #CabinetDecisions

The focus on investing in the industrialization of biology is crucial for addressing urgent issues like climate change, food security, and health. By promoting sustainable and circular practices, this initiative aims to build a stronger and more resilient biomanufacturing

India’s new Biotech Policy outlines ambitious goals to foster innovation through support for R&D and entrepreneurship. It includes plans for establishing Biomanufacturing, Biofoundry, and Bio-AI Hubs, which will drive economic growth and job creation. The policy aims to set

The Bioenablers initiative introduces advanced facilities such as Bio-Artificial Intelligence Hubs for analyzing large-scale biological data, Biomanufacturing Hubs for turning R&D into bio based products, and Biofoundries for scaling biological engineering. #CabinetDecisions

The future of India’s biotech industry includes developing biopharmaceuticals and smart proteins, transitioning to a bio-based economy, and utilizing waste for bio-production. These advancements aim to support the goal of Net Zero Carbon Emissions and create employment

India’s biotech sector is expected to experience substantial growth, with the bioeconomy projected to reach ₹24,000 Billion by 2030 and contribute 5-6% of the country’s GDP. Biomanufacturing will play a crucial role in this expansion, acting as a catalyst for economic

Exciting times ahead for Biotech innovation in India

Official poster out 🤩 EMBO #TB Host and Pathogen #Heterogenity #Hyderabad #India CCMB A*STAR Infectious Diseases (ID) Labs Priscille Brodin EMBO Mol. Medicine ICGEB, New Delhi - 25 Invited speakers - 50 Abstracts - Flash talk - 12 Abstracts - Short talk - Travel grants - Reg. fee include accomodation

Deadline for Abstract Submission and Registration: 20th October 2024! #EMBOtuberculosis CSIR-CCMB ICGEB, New Delhi Amit Singhal Department of Biotechnology ICMR

A new axis of pathogenicity in #tuberculosis involving #neutrophils and a strategy to improve TB prevention and control! ICGEB, New Delhi Department of Biotechnology Amit Singhal doi.org/10.7554/eLife.… eLife - the journal

Submit your Abstract before 20th October. Many slots for short talks from selected abstracts! #tuberculosis #EMBOtuberculosis CSIR, India Department of Biotechnology ICMR

Applications are open for the 2025 FluoMicro course ICGEB, New Delhi! Last date of application: 20th March. ICGEB Official icgeb.org/fluomicroicgeb…

On #WorldTBDay, held at Vigyan Bhavan, Dr. Dhiraj Kumar, Group Leader, Cellular Immunology Group ICGEB, New Delhi providing an insightful briefing on the role of ICGEB, New Delhi as a key partner in the Tuberculosis Genomic Surveillance Consortium (InTGS)—a joint initiative by the

pnas.org/doi/10.1073/pn… Latest from the lab. ICGEB Official ICGEB, New Delhi Department of Biotechnology Excellent collaboration with Vinay CCMB AIIMS, New Delhi 🇮🇳 and Amit Singhal Thanks to support from DBT/WT India Alliance

#NewResearch Alert ! New study from #CellularImmunologyGroup ICGEB, New Delhi, uncovers how Mycobacterium tuberculosis hijacks host RNA splicing to weaken immune defenses. Disabling this mechanism significantly impairs bacterial survival. Stay tuned-in for a video explainer, which

Tuberculosis bacteria hijack our gene expression—latest study from our #CellularImmunologyGroup reveals how Mtb rewires RNA splicing to outsmart our immune system. Watch the video here ! You can access the full paper here:: pnas.org/doi/10.1073/pn…

Presenting DBTiBRIC+ #SuccessStories Meet Dr. Dhiraj Kumar, Group Leader of the Cellular Immunology Group at the ICGEB, New Delhi. His research reveals how Mycobacterium tuberculosis #Mtb hijacks host RNA splicing mechanisms to disrupt immune responses—an advanced tactic the